Oxytocin (Syntocinon)

CAS No. 50-56-6

Oxytocin (Syntocinon)( Oxytocic hormone | Oxytocin | α-Hypophamine )

Catalog No. M19806 CAS No. 50-56-6

Oxytocin is a mammalian neurohypophysial hormone a ligand of oxytocin receptor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 36 In Stock
10MG 51 In Stock
25MG 85 In Stock
50MG 124 In Stock
100MG 188 In Stock
200MG 293 In Stock
500MG 534 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Oxytocin (Syntocinon)
  • Note
    Research use only, not for human use.
  • Brief Description
    Oxytocin is a mammalian neurohypophysial hormone a ligand of oxytocin receptor.
  • Description
    Oxytocin is a mammalian neurohypophysial hormone a ligand of oxytocin receptor.
  • In Vitro
    ——
  • In Vivo
    During the LMA task, rat core body temperature are modestly decreased.?Oxytocin (subcutaneous?injection; 0.1?mg/kg-0.3 mg/kg; single dose) produces significantly greater hypothermia (at 0.3 mg/kg) than either saline or the two lower doses of oxytocin. Oxytocin at 0.3?mg/kg produces a significantly greater decrease in temperature than vehicle between 15-60?min post injection, whereas 0.1?mg/kg slightly decreases temperature at the 30?min time point only.Oxytocin (0.1?mg/kg) engages in significantly more body sniffing and ano-genital sniffing compared with saline controls. It also increases the total time spent in social interaction (71.6±4.3?s), compared to those receiving vehicle (56.9±4.1?s). Animal Model:Fifty-six male Lister-hooded rats (150-200?g) Dosage:0.1?mg/kg-0.3 mg/kg Administration:Subcutaneous?injection; 0.1?mg/kg-0.3 mg/kg; single dose Result:Produced significantly greater hypothermia (at 0.3 mg/kg) than the saline group.
  • Synonyms
    Oxytocic hormone | Oxytocin | α-Hypophamine
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Oxytocin Receptor
  • Research Area
    Others
  • Indication
    Labour disorders

Chemical Information

  • CAS Number
    50-56-6
  • Formula Weight
    1007.19
  • Molecular Formula
    C43H66N12O12S2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • YPC-22026

    YPC-22026 has potential anticancer activity, inducing tumor regression in a mouse xenograft model while inhibiting ZNF143-regulated genes.

  • OGT-IN-2

    OGT-IN-2 is a potent O-GlcNAc transferase (OGT) inhibitor. OGT-IN-2 inhibits sOGT and ncOGT with IC50 values of 30 μM and 53 μM, respectively. OGT-IN-2 can be used for the research of articular diseases.

  • Linzagolix

    Linzagolix is a small-molecule, non-peptide, orally active gonadotropin-releasing hormone antagonist (GnRH antagonist) which is under development by Kissei Pharmaceutical and ObsEva for the treatment of uterine fibroids, endometriosis, and adenomyosis.